Syndax Pharmaceuticals Inc has filed 641 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-14 | Other Events; Financial Statements and Exhibits |
| 4 | 2026-07-09 | Statement of Changes in Beneficial Ownership |
| 4 | 2026-06-12 | Statement of Changes in Beneficial Ownership |
| 8-K | 2026-06-10 | Departure/Appointment of Directors or Officers; Submission of Matters to a Vote of Security Holders |
| 8-K | 2026-06-10 | Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation |
| 8-K | 2026-06-04 | Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation |
| DEFA14A | 2026-06-04 | Additional Proxy Soliciting Materials |
| 4 | 2026-06-02 | Statement of Changes in Beneficial Ownership |
| 4 | 2026-06-02 | Statement of Changes in Beneficial Ownership |
| SC 13G/A | 2026-05-15 | Beneficial Ownership Report (Passive, Amended) |